Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Current Taxes: 2019-2022

Historic Current Taxes for Nurix Therapeutics (NRIX) over the last 2 years, with Aug 2022 value amounting to $41,000.

  • Nurix Therapeutics' Current Taxes rose 10.81% to $41,000 in Q3 2022 from the same period last year, while for Aug 2022 it was $41,000, marking a year-over-year increase of 10.81%. This contributed to the annual value of $75,000 for FY2021, which is 1.35% up from last year.
  • Per Nurix Therapeutics' latest filing, its Current Taxes stood at $41,000 for Q3 2022, which was up 57.69% from $26,000 recorded in Q2 2022.
  • Nurix Therapeutics' 5-year Current Taxes high stood at $325,000 for Q1 2021, and its period low was $26,000 during Q2 2022.
  • Over the past 3 years, Nurix Therapeutics' median Current Taxes value was $47,000 (recorded in 2022), while the average stood at $83,125.
  • In the last 5 years, Nurix Therapeutics' Current Taxes soared by 124.24% in 2020 and then slumped by 83.69% in 2022.
  • Over the past 4 years, Nurix Therapeutics' Current Taxes (Quarterly) stood at $33,000 in 2019, then surged by 124.24% to $74,000 in 2020, then rose by 1.35% to $75,000 in 2021, then climbed by 10.81% to $41,000 in 2022.
  • Its Current Taxes stands at $41,000 for Q3 2022, versus $26,000 for Q2 2022 and $53,000 for Q1 2022.